Yu Li 4
4 · Oncocyte Corp · Filed May 19, 2022
Insider Transaction Report
Form 4
Yu Li
VP Cntrllr/Prncpl Acctng Offcr
Transactions
- Exercise/Conversion
Common Stock, no par value
2022-05-18+25,000→ 25,000 total - Exercise/Conversion
Restricted Stock Units
2022-05-18−25,000→ 25,000 totalExercise: $0.00→ Common Stock (25,000 underlying) - Sale
Common Stock, no par value
2022-05-18$1.14/sh−8,128$9,266→ 16,872 total
Footnotes (2)
- [F1]Represents shares sold to cover the tax liability arising from the vesting of Restricted Stock Units.
- [F2]Restricted Stock Units vested on May 18, 2022.